Stay updated on Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.

Latest updates to the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page
- CheckyesterdayChange DetectedDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a phase II trial for pembrolizumab and interferon gamma-1b in treating mycosis fungoides and Sezary syndrome, while adding new identifiers and conditions related to various cancer types.SummaryDifference63%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedDifference0.2%
Stay in the know with updates to Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.